Discontinued — last reported Q2 '25

Current Assets

Finished goods

Medtronic Finished goods decreased by 0.0% to $4.19B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.1%, from $3.74B to $4.19B. Over 4 years (FY 2021 to FY 2025), Finished goods shows an upward trend with a 6.8% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ3 2017
Last reportedQ2 2025
Parent metricInventories

How to read this metric

An increase relative to sales may signal slowing demand or overproduction; a decrease may indicate strong sales or supply chain constraints.

Detailed definition

This represents the value of inventory that has completed the manufacturing process and is ready for sale to customers....

Peer comparison

Standard inventory metric for all manufacturing and retail companies.

Metric ID: inv_finished_goods

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$2.88B$2.91B$3.00B$3.07B$3.15B$3.32B$3.55B$3.44B$3.72B$3.78B$3.80B$3.67B$3.73B$3.73B$3.74B$3.78B$4.02B$4.20B$4.19B
QoQ Change+0.8%+3.1%+2.4%+2.4%+5.5%+6.9%-3.0%+8.2%+1.4%+0.6%-3.4%+1.7%-0.1%+0.3%+1.0%+6.4%+4.3%-0.0%
YoY Change+9.0%+14.1%+18.3%+12.1%+18.4%+13.8%+7.2%+6.6%+0.2%-1.2%-1.6%+3.0%+7.8%+12.5%+12.1%
% of Inventories67.3%66.9%66.4%66.5%65.4%65.6%66.0%65.0%65.7%65.6%66.3%70.3%68.9%68.1%66.7%69.0%68.3%68.1%66.5%
Share Change-0.4pp-0.5pp+0.1pp-1.1pp+0.2pp+0.3pp-1.0pp+0.7pp-0.1pp+0.7pp+4.0pp-1.4pp-0.9pp-1.4pp+2.3pp-0.7pp-0.2pp-1.7pp
Range$2.88B$4.20B
CAGR+8.7%
Avg YoY Growth+8.8%
Median YoY Growth+9.0%

Frequently Asked Questions

What is Medtronic's finished goods?
Medtronic (MDT) reported finished goods of $4.19B in Q4 2025.
How has Medtronic's finished goods changed year-over-year?
Medtronic's finished goods increased by 12.1% year-over-year, from $3.74B to $4.19B.
What is the long-term trend for Medtronic's finished goods?
Over 4 years (2021 to 2025), Medtronic's finished goods has grown at a 6.8% compound annual growth rate (CAGR), from $2.91B to $3.78B.
What does finished goods mean?
The value of completed products ready for sale.